AAAAAA

   
Results: 1-18 |
Results: 18
REVERSE TRANSCRIPTION-POLYMERASE CHAIN-REACTION IS A RELIABLE ASSAY FOR DETECTING LEUKEMIC COLONIES GENERATED BY CHRONIC MYELOGENOUS LEUKEMIA-CELLS
Authors: SAVOLDO B SAMMARELLI G DOTTI G GARAU D REGAZZI E CILLONI D TABILIO A RIZZOLI V CARLOSTELLA C
Citation: B. Savoldo et al., REVERSE TRANSCRIPTION-POLYMERASE CHAIN-REACTION IS A RELIABLE ASSAY FOR DETECTING LEUKEMIC COLONIES GENERATED BY CHRONIC MYELOGENOUS LEUKEMIA-CELLS, Leukemia, 12(3), 1998, pp. 434-440
EXPRESSION OF P190 AND P210 BCR-ABL IN CML-DERIVED CD34(+), CD34(+) AND CD15(+)
Authors: CARLOSTELLA C SAVOLDO B SAMMARELLI G GARAU D REGAZZI E CILLONI D DEMICHELI D RIZZOLI V SAGLIO G
Citation: C. Carlostella et al., EXPRESSION OF P190 AND P210 BCR-ABL IN CML-DERIVED CD34(+), CD34(+) AND CD15(+), Experimental hematology, 26(8), 1998, pp. 269-269
CLONALITY OF HEMATOPOIETIC-CELL SUBPOPULATIONS IN ESSENTIAL THROMBOCYTOPENIA
Authors: CILLONI D GARAU D SAMMARELLI G SAVOLDO B TABILIO A SAGLIO G RIZZOLI V CARLOSTELLA C
Citation: D. Cilloni et al., CLONALITY OF HEMATOPOIETIC-CELL SUBPOPULATIONS IN ESSENTIAL THROMBOCYTOPENIA, Experimental hematology, 26(8), 1998, pp. 412-412
EFFECT OF THE BCR-ABL-SPECIFIC INHIBITOR AG957 ON CHRONIC MYELOGENOUSLEUKEMIA PROGENITOR CELLS
Authors: CARLOSTELLA C SAVOLDO B SAMMARELLI G REGAZZI E GARAU D MANGONI L GAZIT A LEVITZKI A RIZZOLI V
Citation: C. Carlostella et al., EFFECT OF THE BCR-ABL-SPECIFIC INHIBITOR AG957 ON CHRONIC MYELOGENOUSLEUKEMIA PROGENITOR CELLS, Bone marrow transplantation, 21, 1998, pp. 298-298
DETECTION OF BREAST-CANCER CELLS USING THE MAGNETIC CELL-SEPARATION (MACS) SYSTEM - IMPLICATIONS FOR STEM-CELL PURGING
Authors: GARAU D REGAZZI E SAVOLDO B SAMMARELLI G RIZZOLI V CARLOSTELLA C
Citation: D. Garau et al., DETECTION OF BREAST-CANCER CELLS USING THE MAGNETIC CELL-SEPARATION (MACS) SYSTEM - IMPLICATIONS FOR STEM-CELL PURGING, European journal of histochemistry, 41, 1997, pp. 17-18
USE OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) IN COMBINATION WITH HYDROXYUREA AS POSTTRANSPLANT THERAPY IN CHRONIC MYELOGENOUS LEUKEMIA PATIENTS AUTOGRAFTED WITH UNMANIPULATED HEMATOPOIETIC-CELLS
Authors: CARLOSTELLA C REGAZZI E ANDRIZZI C SAVOLDO B GARAU D MONTEFUSCO E VIGNETTI M MANDELLI F RIZZOLI V MELONI G
Citation: C. Carlostella et al., USE OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) IN COMBINATION WITH HYDROXYUREA AS POSTTRANSPLANT THERAPY IN CHRONIC MYELOGENOUS LEUKEMIA PATIENTS AUTOGRAFTED WITH UNMANIPULATED HEMATOPOIETIC-CELLS, Haematologica, 82(3), 1997, pp. 291-296
EFFECT OF AG957, A BCR-ABL-SPECIFIC TYROSINE KINASE INHIBITOR, ON CHRONIC MYELOGENOUS LEUKEMIA PROGENITOR CELLS
Authors: CARLOSTELLA C REGAZZI E GARAU D SAVOLDO B SAMMARELLI G RIZZO MT LEVITZKI A RIZZOLI V
Citation: C. Carlostella et al., EFFECT OF AG957, A BCR-ABL-SPECIFIC TYROSINE KINASE INHIBITOR, ON CHRONIC MYELOGENOUS LEUKEMIA PROGENITOR CELLS, Experimental hematology, 25(8), 1997, pp. 188-188
CLONOGENIC CELL CONTENT OF CHRONIC MYELOGENOUS LEUKEMIA CD34(+) CELLSLACKING CD95 EXPRESSION
Authors: RIZZOLI V GARAU D REGAZZI E SAVOLDO B SAMMARELLI G MANGONI L ALMICI C TABILIO A RIZZO MT CARLOSTELLA C
Citation: V. Rizzoli et al., CLONOGENIC CELL CONTENT OF CHRONIC MYELOGENOUS LEUKEMIA CD34(+) CELLSLACKING CD95 EXPRESSION, Experimental hematology, 25(8), 1997, pp. 189-189
AMIFOSTINE PRETREATMENT ALLOWS THE USE OF HIGHER DOSES OF THE BCR-ABL-SPECIFIC TYROSINE KINASE INHIBITOR AG1112
Authors: CILLONI D LEVITZKI A REGAZZI E GARAU D SAVOLDO B SAMMARELLI G ALMICI C RIZZOLI V CARLOSTELLA C
Citation: D. Cilloni et al., AMIFOSTINE PRETREATMENT ALLOWS THE USE OF HIGHER DOSES OF THE BCR-ABL-SPECIFIC TYROSINE KINASE INHIBITOR AG1112, Experimental hematology, 25(8), 1997, pp. 376-376
ABSENCE OF VARIABLE TRANSCRIPTION OF THE BCR-ABL FUSION GENE BY PH-POSITIVE PROGENITORS FROM MONONUCLEAR AND CD34(+) CELLS
Authors: SAVOLDO B SAMMARELLI G REGAZZI E GARAU D MANGONI L TABILIO A RIZZOLI V CARLOSTELLA C
Citation: B. Savoldo et al., ABSENCE OF VARIABLE TRANSCRIPTION OF THE BCR-ABL FUSION GENE BY PH-POSITIVE PROGENITORS FROM MONONUCLEAR AND CD34(+) CELLS, Experimental hematology, 25(8), 1997, pp. 629-629
SHC OVEREXPRESSION PREVENTS APOPTOSIS AND INDUCES HYPERSENSITIVITY TOGM-CSF OF THE GM-CSF-DEPENDENT AML CELL-LINE GF-D8
Authors: GARAU D CARLOSTELLA C REGAZZI E SAVOLDO B RIZZOLI V PELICCI PG LANFRANCONE L DOTTI GP SPINELLI O BARBUI T RAMBALDI A
Citation: D. Garau et al., SHC OVEREXPRESSION PREVENTS APOPTOSIS AND INDUCES HYPERSENSITIVITY TOGM-CSF OF THE GM-CSF-DEPENDENT AML CELL-LINE GF-D8, European journal of cell biology, 72, 1997, pp. 75-75
EFFECT OF THE BCR-ABL-SPECIFIC INHIBITOR AG957 ON CHRONIC MYELOGENOUSLEUKEMIA PROGENITOR CELLS
Authors: CARLOSTELLA C SAVOLDO B SAMMARELLI G REGAZZI E GARAU D ALMICI C MANGONI L GAZIT A LEVITZKI A RIZZOLI V
Citation: C. Carlostella et al., EFFECT OF THE BCR-ABL-SPECIFIC INHIBITOR AG957 ON CHRONIC MYELOGENOUSLEUKEMIA PROGENITOR CELLS, Blood, 90(10), 1997, pp. 350-350
SHC PROTEINS PHOSPHORYLATION IN CHRONIC MYELOGENOUS LEUKEMIA
Authors: BONATI A CARLOSTELLA C LUNGHI P ALBERTINI R PINELLI S MIGLIACCIO E SAMMARELLI G SAVOLDO B TABILIO A RIZZOLI V DALLAGLIO PP PELICCI PG
Citation: A. Bonati et al., SHC PROTEINS PHOSPHORYLATION IN CHRONIC MYELOGENOUS LEUKEMIA, Blood, 90(10), 1997, pp. 863-863
GENISTEIN TRIGGERS APOPTOSIS OF CHRONIC MYELOGENOUS LEUKEMIA-CELLS AND SELECTS BCR ABL NEGATIVE PROGENITORS/
Authors: RIZZOLI V REGAZZI E DOTTI G MANGONI L GARAU D RIZZO MT SAVOLDO B BONATI A CARLOSTELLA C
Citation: V. Rizzoli et al., GENISTEIN TRIGGERS APOPTOSIS OF CHRONIC MYELOGENOUS LEUKEMIA-CELLS AND SELECTS BCR ABL NEGATIVE PROGENITORS/, Experimental hematology, 24(9), 1996, pp. 646-646
SELECTION OF MYELOID PROGENITORS LACKING BCR ABL MESSENGER-RNA IN CHRONIC MYELOGENOUS LEUKEMIA PATIENTS AFTER IN-VITRO TREATMENT WITH THE TYROSINE KINASE INHIBITOR GENISTEIN/
Authors: CARLOSTELLA C DOTTI G MANGONI L REGAZZI E GARAU D BONATI A ALMICI C SAMMARELLI G SAVOLDO B RIZZO MT RIZZOLI V
Citation: C. Carlostella et al., SELECTION OF MYELOID PROGENITORS LACKING BCR ABL MESSENGER-RNA IN CHRONIC MYELOGENOUS LEUKEMIA PATIENTS AFTER IN-VITRO TREATMENT WITH THE TYROSINE KINASE INHIBITOR GENISTEIN/, Blood, 88(8), 1996, pp. 3091-3100
SHC OVEREXPRESSION INDUCES SELECTIVE HYPERSENSITIVITY TO GM-CSF AND PREVENTS APOPTOSIS OF THE GM-CSF-DEPENDENT AML CELL-LINE GF-DB
Authors: STELLA CC DOTTI GP SPINELLI O SAVOLDO B GARAU D REGAZZI E RIZZOLI V BARBUI T PELICCI PG LANFRANCONE L RAMBALDI A
Citation: Cc. Stella et al., SHC OVEREXPRESSION INDUCES SELECTIVE HYPERSENSITIVITY TO GM-CSF AND PREVENTS APOPTOSIS OF THE GM-CSF-DEPENDENT AML CELL-LINE GF-DB, Blood, 88(10), 1996, pp. 783-783
CHRONIC MYELOGENOUS LEUKEMIA CD34(-CELLS LACKING CD95 EXPRESSION ARE ENRICHED FOR BCR() MARROW)ABL NEGATIVE PRIMITIVE AND COMMITTED PROGENITORS/
Authors: CARLOSTELLA C SAVOLDO B REGAZZI E GARAU D SAMMARELLI G MANGONI L ALMICI C FRASSONI F RIZZOLI V
Citation: C. Carlostella et al., CHRONIC MYELOGENOUS LEUKEMIA CD34(-CELLS LACKING CD95 EXPRESSION ARE ENRICHED FOR BCR() MARROW)ABL NEGATIVE PRIMITIVE AND COMMITTED PROGENITORS/, Blood, 88(10), 1996, pp. 2284-2284
IN-VITRO SELECTION OF MYELOID PROGENITORS LACKING BCR-ABL IN CHRONIC MYELOGENOUS LEUKEMIA PATIENTS AFTER TREATMENT WITH GENISTEIN
Authors: CARLOSTELLA C DOTTI G MANGONI L REGAZZI E GARAU D RIZZO MT SAVOLDO B ALMICI C RIZZOLI V
Citation: C. Carlostella et al., IN-VITRO SELECTION OF MYELOID PROGENITORS LACKING BCR-ABL IN CHRONIC MYELOGENOUS LEUKEMIA PATIENTS AFTER TREATMENT WITH GENISTEIN, Blood, 86(10), 1995, pp. 2395-2395
Risultati: 1-18 |